- Home
- NLOP vs ZVRA Comparison
NLOP vs ZVRA Comparison
Compare NLOP & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLOP
- ZVRA
- Stock Information
- Founded
- NLOP N/A
- ZVRA 2006
- Country
- NLOP United States
- ZVRA United States
- Employees
- NLOP N/A
- ZVRA N/A
- Industry
- NLOP
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- NLOP
- ZVRA Health Care
- Exchange
- NLOP Nasdaq
- ZVRA Nasdaq
- Market Cap
- NLOP 428.9M
- ZVRA 499.9M
- IPO Year
- NLOP N/A
- ZVRA 2015
- Fundamental
- Price
- NLOP $28.94
- ZVRA $8.65
- Analyst Decision
- NLOP Strong Buy
- ZVRA Strong Buy
- Analyst Count
- NLOP 1
- ZVRA 7
- Target Price
- NLOP $46.00
- ZVRA $21.71
- AVG Volume (30 Days)
- NLOP 57.9K
- ZVRA 1.6M
- Earning Date
- NLOP 11-07-2025
- ZVRA 11-05-2025
- Dividend Yield
- NLOP 10.69%
- ZVRA N/A
- EPS Growth
- NLOP N/A
- ZVRA N/A
- EPS
- NLOP N/A
- ZVRA 0.54
- Revenue
- NLOP $115,901,000.00
- ZVRA $84,388,000.00
- Revenue This Year
- NLOP N/A
- ZVRA $336.43
- Revenue Next Year
- NLOP N/A
- ZVRA $54.26
- P/E Ratio
- NLOP N/A
- ZVRA $16.07
- Revenue Growth
- NLOP N/A
- ZVRA 244.60
- 52 Week Low
- NLOP $26.10
- ZVRA $6.19
- 52 Week High
- NLOP $34.53
- ZVRA $13.16
- Technical
- Relative Strength Index (RSI)
- NLOP 42.48
- ZVRA 38.27
- Support Level
- NLOP $28.75
- ZVRA $8.01
- Resistance Level
- NLOP $29.80
- ZVRA $9.95
- Average True Range (ATR)
- NLOP 0.44
- ZVRA 0.63
- MACD
- NLOP -0.07
- ZVRA -0.08
- Stochastic Oscillator
- NLOP 16.56
- ZVRA 25.07
About NLOP Net Lease Office Properties of Beneficial Interest
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.